Ohio SB434 mandates pharmacists to provide educational materials and surveys on opioid and benzodiazepine risks to patients.

Ohio SB434, known as the Verified Opioid and Intoxicant Consumer Education (VOICE) Act, requires pharmacists to provide educational materials and surveys to patients receiving initial prescriptions for benzodiazepines or opioid analgesics. These materials cover addiction risks, signs of misuse, safe use, disposal, alternative pain treatments, and resources for intervention and treatment. Exemptions apply for cancer treatment, hospice care, and palliative care. The educational materials and surveys can be provided digitally or in paper form, depending on the patient's access.

Ohio SB434 mandates pharmacists to provide educational materials and surveys on opioid and benzodiazepine risks to patients.

Ohio SB434, known as the Verified Opioid and Intoxicant Consumer Education (VOICE) Act, requires pharmacists to provide educational materials and surveys to patients receiving initial prescriptions for benzodiazepines or opioid analgesics. These materials cover addiction risks, signs of misuse, safe use, disposal, alternative pain treatments, and resources for intervention and treatment. Exemptions apply for cancer treatment, hospice care, and palliative care. The educational materials and surveys can be provided digitally or in paper form, depending on the patient's access.